New Generation Of Antidepressants On FDA Fast Track

The medications, which are still in development, may be able to help those who have not found success with currently available antidepressants. Pharmaceutical companies are honing in on the potential of ketamine and more to provide fast-acting antidepressant relief, Healthline reports. Two examples are Janssen Pharmaceuticals’ esketamine nasal spray and Allergan’s rapastinel (a different, but… Continue reading New Generation Of Antidepressants On FDA Fast Track

Exit mobile version